Novanta (NOVT) - 2023 Q4 - Earnings Call Transcript

In addition to all of this in 2023, we signed an agreement to acquire Motion Solutions which will enhance our portfolio and further expand our presence in the highly attractive medical and precision medicine space. We're happy to have completed the acquisition at the beginning of January 2024. Going into more detail, for the full year of 2023, sales to medical markets made up approximately 54% of total Novanta sales and grew 13% versus the prior year, driven by strong double-digit growth in minimally invasi ...